Inventor
JOHNSON ROBERT C
US101 patents
⚠️ This page may combine multiple inventors who share the name “JOHNSON ROBERT C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HONEYWELL INT INC
11 patentsUS7829748B1Nov 9, 2010
Process for the manufacture of 1,3,3,3-tetrafluoropropene
HONEYWELL INT INC63 citations98
US7985299B2Jul 26, 2011
Solvent compositions containing chlorofloroolefins or fluoroolefins
HONEYWELL INT INC17 citations93
US7951982B2May 31, 2011
Method for producing fluorinated organic compounds
HONEYWELL INT INC27 citations93
US7674756B2Mar 9, 2010
Solvent compositions containing chlorofluoroolefins or fluoroolefins
HONEYWELL INT INC21 citations93
US7592494B2Sep 22, 2009
Process for the manufacture of 1,3,3,3-tetrafluoropropene
HONEYWELL INT INC26 citations93
US7880040B2Feb 1, 2011
Method for producing fluorinated organic compounds
HONEYWELL INT INC31 citations92
US7026521B1Apr 11, 2006
Methane and methyl chloride as selective reducing agent in the transformation of hydrochlorofluorocarbons or chlorofluorocarbons to hydrofluorocarbons
HONEYWELL INT INC20 citations92
US6759381B1Jul 6, 2004
Azeotrope-like compositions of 1-chloro-1,3,3,3-tetrafluoropropane and 1,2-dichloro-3,3,3-trifluoropropene
HONEYWELL INT INC36 citations92
US9586071B2Mar 7, 2017
Compositions containing chlorofluoroolefins or fluoroolefins
HONEYWELL INT INC3 citations84
US9181151B2Nov 10, 2015
Process to manufacture 2-chloro-1,1,1,2-tetrafluoropropane (HCFC-244bb)
HONEYWELL INT INC8 citations84
US8974690B2Mar 10, 2015
Compositions containing chlorfluoroolefins or fluoroolefins
HONEYWELL INT INC5 citations84
BAXTER INT
10 patentsUS6773458B1Aug 10, 2004
Angiogenic tissue implant systems and methods
BAXTER INT557 citations99
US5964804AOct 12, 1999
Close vascularization implant material
BAXTER INT301 citations99
US5882354AMar 16, 1999
Close vascularization implant material
BAXTER INT164 citations99
US5800529ASep 1, 1998
Close vascularization implant material
BAXTER INT428 citations99
US5782912AJul 21, 1998
Close vascularization implant material
BAXTER INT394 citations99
US5741330AApr 21, 1998
Close vascularization implant material
BAXTER INT462 citations99
US5593440AJan 14, 1997
Tissue implant systems and methods for sustaining viable high cell densities within a host
BAXTER INT525 citations99
US5314471AMay 24, 1994
Tissue inplant systems and methods for sustaining viable high cell densities within a host
BAXTER INT756 citations99
US5569462AOct 29, 1996
Methods for enhancing vascularization of implant devices
BAXTER INT410 citations98
US4920098AApr 24, 1990
Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
BAXTER INT277 citations96
SCHERING PLOUGH HEALTHCARE
4 patentsTEITELBAUM JACOB
4 patentsMERKEL DANIEL C
3 patentsUS8058486B2Nov 15, 2011
Integrated process to produce 2,3,3,3-tetrafluoropropene
MERKEL DANIEL C143 citations98
US8664455B2Mar 4, 2014
Process to manufacture 2-chloro-1,1,1,2-tetrafluoropropane (HCFC-244bb)
MERKEL DANIEL C12 citations93
US9024092B2May 5, 2015
Method for producing fluorinated organic compounds
MERKEL DANIEL C6 citations84
PROCTER & GAMBLE
3 patentsREYNOLDS TOBACCO CO R
2 patentsJOHNSON ROBERT C
1 patent(unassigned)
1 patentTORO CO
1 patentDU PONT
1 patentBREEDEN WINSTON
1 patentHON IND INC
1 patentTOCCO INC
1 patentSEITH NANCY
1 patentSCHERING PLOUGH HEALTH CARE PRODUCTS INC
1 patentWIGHTMAN JAMES C
1 patentROTHSCHILD JEFFREY
1 patentFORD MOTOR CO
1 patentBUCKEYE CELLULOSE CORP
1 patentShowing the top 50 of 101 patents by PatentIndex Score.